chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"left arm is not as sore today"; left "arm felt like it was going to fall off"; "was in tears"; face became flushed; "flu-type symptoms"; couldn't hardly move her left arm; "achy feeling"; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (left "arm felt like it was going to fall off"), CRYING ("was in tears"), FLUSHING (face became flushed), INFLUENZA LIKE ILLNESS ("flu-type symptoms") and VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't hardly move her left arm) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included High cholesterol. Concomitant products included PRAVASTATIN for High cholesterol.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 04-Feb-2021, the patient experienced LIMB DISCOMFORT (left "arm felt like it was going to fall off"), CRYING ("was in tears"), FLUSHING (face became flushed), INFLUENZA LIKE ILLNESS ("flu-type symptoms"), VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't hardly move her left arm) and PAIN ("achy feeling"). On 05-Feb-2021, the patient experienced MYALGIA ("left arm is not as sore today"). At the time of the report, LIMB DISCOMFORT (left "arm felt like it was going to fall off"), CRYING ("was in tears"), FLUSHING (face became flushed), INFLUENZA LIKE ILLNESS ("flu-type symptoms"), VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't hardly move her left arm), PAIN ("achy feeling") and MYALGIA ("left arm is not as sore today") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included two baby aspirin tablets for the adverse events.
Developed hives and rash at and near injection site 8 days after vaccination.  Swollen and red but no streaks or sign of infection, no fever, just hives on arm.
Received earlier than 4 day grace period. Due 05/08/2021  - received on 05/01/2021
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On 17-NOV-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # J013394 with expiration date 25-AUG-2016. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
In November 1999, the patient developed varicella with a high fever. Additional information has been requested.
Swollen lymph nodes; Redness at the site of injection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes) and VACCINATION SITE ERYTHEMA (Redness at the site of injection) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes) and VACCINATION SITE ERYTHEMA (Redness at the site of injection). At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes) and VACCINATION SITE ERYTHEMA (Redness at the site of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact
Child was waiting the prescribed 15 minutes in the lobby after MENVEO, when about 10 minutes into the wait she began to feel very nauseated, clammy, and dizzy.  Child didnot lose consciousness.  Used cold gel pack to back of child's neck and forehead and gave her sips of cold water.  Child felt better after about 10 minutes and was able to leave with mother another 10 minutes after that.
Constant feelings of vertigo from 7/17/21 to as of writing report (7/20/21 12:16pm CST)
PT was given wrong dosage. PT is 3 years old and was given Pfizer vaccine from 5-11 age group instead of the 6 months to 4 years of age group.
Sore arm; Fatigue; Nausea; Diarrhea; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12May2021 at 10:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic nerve pain, referred nerve pain migraines, penicillin allergy and known allergies to dawn dish soap (soap allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) from 10May2021 taken for an unknown indication, and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 16:00, the patient experienced sore arm, fatigue, brain fog, nausea and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, fatigue, brain fog, nausea and diarrhea was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from an office manager and refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical histories, drug reactions or allergies and concomitant medications were not reported. On unknown dates approximately in November 2016, the patients were vaccinated with improperly stored doses of VAQTA injection, lot # M027879, expiration date 24-JAN-2018, LOT #M036459, expiration date 18-JAN-2018 and lot # M001815, expiration date 20-SEP-2017 (dose, route and site of administration were not reported). No adverse effects were reported. Product quality complaint was not involved. The administered doses of VAQTA were stored in the temperature of 47.7 degrees Fahrenheit for 45 minutes of 18-NOV-2016, then in the temperature of 47.5 degrees Fahrenheit for 15 minutes, in the temperature of 48.4 degrees Fahrenheit for 30 minutes and in the temperature of 31.6 degrees Fahrenheit for 5.5 hours (1 cycle) on 19-NOV-2016, then in the temperature of 29.7 degrees Fahrenheit for 11 hours (1 cycles) and in the temperature of 33.4 degrees Fahrenheit for 15 minutes (1 cycle) on 20-NOV-2016. Data logger was involved. There were no previous temperature excursion reported. This is one of several reports received from the same reporter. Additional information has been requested.
Sore arm; Very tired; Headache; Burning sensation; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), BURNING SENSATION (Burning sensation), FATIGUE (Very tired) and HEADACHE (Headache) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 07-Feb-2021, the patient experienced BURNING SENSATION (Burning sensation) and HEADACHE (Headache). On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Very tired). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Very tired) had resolved and BURNING SENSATION (Burning sensation) and HEADACHE (Headache) outcome was unknown. Not Provided          No concomitant medications were reported. No laboratory details were  provided. No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: TCR received: Outcome of the event & 2nd dose was mentioned.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. Pertinent medical history, drug reactions and allergies were not reported. On an unknown date, multiple unspecified patients were vaccinated with ZOSTAVAX (lot #, expiration date, dose and route of administration were not provided). No information regarding concomitant medications were reported. The pharmacist reported that, on an unknown dates, after receiving ZOSTAVAX, the patients experienced similar reactions: a lump the size of a baseball under the injection site that was red, inflamed and itched. The outcome of the events was unknown. The relatedness between the events and the vaccination with ZOSTAVAX was not provided. This is one of several reports received from the same reporter. Additional information has been requested.
Menstruation abnormal; This is a spontaneous report form a non-contactable consumer (patient). A 43-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 31Mar2021 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing. Patient did not have COVID-19 prior to vaccination. Patient did not receive other vaccine in four weeks. Concomitant medications included birth control pill, multivitamin. The patient experienced menstruation abnormal (non-serious) on 01Apr2021 with outcome of unknown. The patient reported period cycle changes. First month period did not come. 2nd month lots if cramping and only spotting. Her periods normally were very consistent. Patient was not tested for COVID-19 after vaccination.  The lot number for bnt162b2 was not provided and will be requested during follow-up.
In the middle of the night/early morning of 4/08 I began to experience symptoms of the stomach flu, with extreme nausea, some vomiting, and extreme diarrhea.  I could not keep any food or water in.  Symptoms started to subside on the evening of Friday 4/09, but came back full force on Saturday 4/10.  I took some pepto bismol which helped to keep things in, but the nausea is just starting to subside, today April 13th.
I had lower abdominal pain and went to the hospital for a CT scan; they found a lump next to my ovaries. I had an emergency surgery appointment to get the lump removed. Upon testing the tissue from the lump, they diagnosed it as calcium buildup/phleboliths in the pelvic area. I was discharged the same day and still in recovery since the procedure.
This non-serious spontaneous case, initially received from other non-health professional on 14-Nov-2018, concerning a female patient of unspecified age. On an unspecified date, the FLUCELVAX QIVc vaccine underwent first temperature excursion with maximum temperature (Tmax) 8.2 degree Celsius for 4 minutes. On 22-Oct-2018, vaccine underwent second temperature excursion with Tmax 9.8 degree Celsius for 23 minutes. On an unspecified date, two temperature excursions were identified after an audit. On 25-Oct-2018, the patient was inadvertently administered FLUCELVAX QIVc (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number: 252672 and expiry date: 30-Jun-2019) which underwent temperature excursion. The patient did not experience any adverse effect after the vaccination. This case is linked to 201805262 (same reporter).
Arthus reaction, redness, swelling and warmth of R arm 1 hour after DTaP administration.
Muscle pain; This is a spontaneous report received from contactable reporter(s) (Physician). Other Case identifier(s): 2022NVX-US-000003929 (Novavax).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Unknown manufacturer), for COVID-19 immunization. The following information was reported: MYALGIA (non-serious), outcome "recovered", described as "Muscle pain".  Additional information:  It was reported the patient experienced 3 months of significant muscle pain.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
The medication expired 7 days ago on 08-18-22 and  today is 08-25-22   Contacted Merck and was instructed that this vaccine does not need to be readministred the potency is good because it has been stored appropriately
Blood clots under skin; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (Blood clots under skin) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (Blood clots under skin) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (Blood clots under skin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by reporter.  No treatment medications provided by the reporter.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Approximately 3 hours post vax, the pt experienced frothy bloody sputum, unconscious was taken to the ER and transferred to the hospital ICU. Tests are pending.
issues with control/ may die from the vaccine; issues with his nervous system; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (issues with control/ may die from the vaccine) and NERVOUS SYSTEM DISORDER (issues with his nervous system) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (issues with control/ may die from the vaccine) and NERVOUS SYSTEM DISORDER (issues with his nervous system). At the time of the report, VACCINATION COMPLICATION (issues with control/ may die from the vaccine) had not resolved and NERVOUS SYSTEM DISORDER (issues with his nervous system) outcome was unknown.            No concomitant medications were reported.  Treatment information was not provided.
Information has been received from a NP concerning a female pt who had an "MMRII IgG antibody titer drawn on 02/04/03 which was 0.84." On 02/26/03 the pt was vaccinated with a booster dose of MMRII (Lot # 641881/0772M).  On 04/29/03 the "pt's MMRII IgG antibody titer was redrawn and it was only 0.90."  The NP reported that she planned on giving the pt another booster. The NP also reported that another pt had a low titer after receiving the MMRII (WAES # 0305USA00715).  She also reported that another pt had an adverse experience after receiving the MMRII vaccine (WAES # 0305USA00049).  Additional information has been requested.
Extreme tiredness, red swollen hard knot on injection arm, fever of 100, headache.
The patient presented to the Urgent Care and reported symptoms of coughing, chest congestion, and sore throat. The patient reported that they were vaccinated for COVID-19 in March of 2021 and was living in Florida at the time. The patient did not report which COVID-19 vaccine she received, but reported that she completed the series. The patient then tested positive for COVID-19 on 8/11/21.
LOWER BACK PAIN (KIDNEYS); CHILLS; FEVER; HEADACHE; This spontaneous report received from a patient via a company representative concerned a 53 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 13-MAR-2021 08:30 for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021 10:30, the subject experienced lower back pain (kidneys). On 13-MAR-2021 10:30, the subject experienced chills. On 13-MAR-2021 10:30, the subject experienced fever. On 13-MAR-2021 10:30, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, fever, and headache on MAR-2021, and had not recovered from lower back pain (kidneys). This report was non-serious.
Vaccines went into 2-8 C thaw state on or about 20-Dec-2021; Received its 30-days Exp date; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 20-Dec-2021) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2022 at 12:46 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 03-Mar-2022 at 12:46 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 20-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received its 30-days Exp date) and PRODUCT STORAGE ERROR (Vaccines went into 2-8 C thaw state on or about 20-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The Ethnicity was reported. No treatment medications were reported.
Shaking,teeth chattering chills, splitting headache, fever of 102, ,bone and muscle aches, vomiting from 7:15 p.m. until 2:00 a.m.  It all started and stopped at about the same time.   Now it is just extreme fatigue.
Nausea; vomiting; body aches; chills; fevers; diarrhea; The patient received the third/booster dose of BNT162b2; This is a spontaneous report from a non-contactable nurse, the patient. A 24-year-old non-pregnant female patient received the third dose (BOOSTER DOSE) of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Nov2021 at 08:45 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and birth control (Unspecified). The patient previously took vancomycin (MANUFACTURER UNKNOWN), hydrocodone (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Dec2020 at 18:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Jan2021 at 18:00 (at the age of 23-years-old) as a single dose for COVID-19 immunisation.  On 19Nov2021 at 23:00, the patient experienced nausea, vomiting, body aches, chills, fevers and diarrhea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with ondansetron (ZOFRAN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nausea, vomiting, body aches, chills, fevers and diarrhea was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Body aches; Chills; Headache/Extremely bad head; could not lift head off the pillow/her head felt heavier than the rest of her body; slept most of the day yesterday; I feel like I can lose my balance; Nauseous; Dizziness; pain over my left eye brow, is literally killing me, like a nagging pain; This is a spontaneous report received from a non-contactable reporter (Consumer) from medical information team. The reporter is the patient.  A 34-year-old female patient received BNT162B2 (BNT162B2), administration date 27Apr2021 16:00 (Lot number: EW 0172) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (Dose 1, Single, Lot number: EW0150), administration date: 06Apr2021, for COVID-19 immunization. The following information was reported: PAIN (non-serious), outcome "unknown", described as "Body aches"; CHILLS (non-serious), outcome "unknown", described as "Chills"; HEADACHE (non-serious), outcome "unknown", described as "Headache/Extremely bad head"; HEAD DISCOMFORT (non-serious), outcome "unknown", described as "could not lift head off the pillow/her head felt heavier than the rest of her body"; HYPERSOMNIA (non-serious), outcome "unknown", described as "slept most of the day yesterday"; BALANCE DISORDER (non-serious), outcome "unknown", described as "I feel like I can lose my balance "; NAUSEA (non-serious), outcome "unknown", described as "Nauseous"; DIZZINESS (non-serious), outcome "unknown", described as "Dizziness"; FACIAL PAIN (non-serious), outcome "unknown", described as "pain over my left eye brow, is literally killing me, like a nagging pain". Additional Information: The patient stated that on 4pm on Tuesday she got the vaccine. On Wednesday (yesterday), basically all day she experienced body aches, chills, head ache, extremely bad head, she could not lift head off the pillow, her head felt heavier than the rest of her body. She slept most of the day yesterday.  She stated, good news, today she was better, except she felt like she can lose her balance,  and have to sit down. She still has a head ache, but not as bad as yesterday. It was really, extremely bad, felt like her head was in two pieces. She asked if she could take any Tylenol for headache. Today, she was feeling nauseous, it went in and out, but does not last too long. She felt like almost throwing up, but then went away. There are moments where she felt like she wanted to throw up like when just talking to you. The dizziness started today, she was still dizzy and she needed to sit down. She was having pain over her left eyebrow, and was literally killing her, like a nagging pain. Since this happened, she has not been able to complete deadlines.  No follow-up attempts are possible. No further information is expected.